Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: JMS who wrote (77)	1/7/1998 12:55:00 PM
From: cardiologist to be	Read Replies (2) \| Respond to of 235

i think you are right on about gdt having breakout earnings on feb 3. my cousin and his partners firmly believe that gdt has a large, better than 50% easily, share of the stent market. they are betting, and they have yet to be wrong, (see profits in avei from 22-66) that gdt will hit 80 after the news. remember, gdt is taking market share from j&j. the worst thing for gdt is if J&j buys avei. the best thing is if gdt buys avei. they will then dominate the stent market easily until 2000. the question may be can gdt afford to buy avei. a better question may be can J&j afford not to. either way, avei will not be a independent concern in 1999.